Purpose To evaluate the efficacy of ultrasonography-guided percutaneous treatment of de Quervain tenosynovitis with the combination of a corticosteroid injection and release of the retinaculum of the first extensor compartment tendons with a 21-gauge needle. Materials and methods The first part of our study consisted of ten procedures on cadaver wrists followed by dissection to analyse the effectiveness of the retinaculum release and detect any collateral damage. The second part was a prospective clinical study of 35 procedures. Outcomes were evaluated through a 6-month clinical follow-up and telephone interview at the end of the study. The following parameters were monitored over time: pain level on a visual analogue scale, the QuickDASH and the PRWE. Patient satisfaction questionnaires were also administered.
Introduction
De Quervain's disease [1] is a specific form of stenosing tenosynovitis in the wrist due to a mismatch between the size of the tendons of the first extensor compartment (abductor pollicis longus (APL) and extensor pollicis brevis (EPB)) and the size of the osteofibrous tunnel in which they are located. This tenosynovitis manifests itself as pain on the radial side of the wrist, which is increased by performing the Finkelstein test [2] . This is a common disease, with 1.2% prevalence [3] . It mostly affects women (prevalence of 1.3-2.8 %) [4, 5] ) particularly some new mothers who develop 'baby wrist' [6] . Men are, however, not immune to this condition (0.6 % [3, 5] ), particularly manual laborers who perform repetitive movements [3] . Ultrasonography (US) is an excellent modality for exploring this condition, as it provides an accurate assessment of the local damage and anatomical variations [7, 8] . Hypoechogenic thickening of the retinaculum is present and measures 2.01 mm on average [8] . It can encompass both tendons without a septum (type 1 according to Volpe et al.) [8] or only the EPB with a septum (type 2) [8] . The presence of this intertendinous septum, which is easily seen with US [9] , contributes to the occurrence of de Quervain's tenosynovitis and increases friction on the EPB [10] . Its frequency varies from 29 % to 81 % of cases, depending on the study [8, 9, [11] [12] [13] . US can also detect a hyperintense Doppler signal in the retinaculum [8] and anatomical tendon variations (multi-fasciculated APL [9] , bifid or absent EPB [9, 14] ).
The initial medical care varies between teams but typically consists of stopping pain-inducing movements, bracing [15] , NSAIDs and corticosteroid injections. If conservative treatment fails, surgical treatment (release of radial styloid pulley) can be proposed to the patient [16] . Various types of reconstruction procedures have been described [17] [18] [19] [20] [21] to prevent the most typical complication -anterior tendon dislocation [22] .
Up to now, the therapeutic role of US was limited to determining the exact location for corticosteroid injection to achieve optimal diffusion within the EPB tendon sheath [23] or around both tendons [24] , thereby reducing the probability of failure [25, 26] . Very few studies apply US-guided percutaneous release in the case of de Quervain's tenosynovitis [11, 27] . The purpose of our study was to evaluate the effectiveness of US-guided release using a 21-gauge (G; 0.8-mm) needle in this pathology, based on our experience with treating trigger finger using this technique [28] .
Materials and methods
Our two-part study was approved by our Research Ethics Committee. It consisted of cadaver and clinical experiments conducted jointly by a hand surgeon (12 years' experience) and an interventional radiologist specializing in musculoskeletal procedures (17 years' experience).
Cadaver study
A feasibility study was performed in cadavers to confirm that the retinaculum of the first compartment of extensor tendons could be cut using a 21-G needle. This release is feasible, but requires ten back-and-forth movements of the needle to be complete (Fig. 1) . Based on these findings, the radiologist performed an US-guided release of the retinaculum of the first compartment in ten wrists of five fresh cadavers (four women and one man, mean age 82 years). Subsequently, the surgeon carefully dissected the treated wrists to analyse the condition of the retinaculum, tendons and adjacent neural and vascular structures. Fig. 1 Transection with a 21-G needle of the retinaculum of the first extensor compartment in a cadaver specimen. Tendons of the first extensor compartment and their retinaculum are exposed after dissection of overlying tissues on the radial side of the wrist of a fresh cadaver (89-year-old female). A 21-G needle is slid longitudinally over the retinaculum using the needle's bevel as a surgical knife. After ten or so back-and-forth passes, the retinaculum is transected (arrows), revealing the extensor pollicis brevis (E) and abductor pollicis longus (A) tendons.
Clinical study

Study population
Over a 2-year period starting in January 2015, 38 patients were included in our prospective study. The inclusion criteria were presence of de Quervain's tenosynovitis for at least 4 months (mean 5.7 months, range 4-12 months) that was recalcitrant to conservative treatment, and a positive Finkelstein test. Patients were excluded if they had previously undergone surgery in the first extensor compartment, had another hand pathology, or were lost to follow-up.
During the consultation before the procedure, the surgeon proposed the US-guided release procedure to 38 patients and obtained written informed consent from each one. Three patients were excluded during the study: two were lost to followup and one developed symptoms of carpal tunnel syndrome. Hence, data from 35 patients (seven men, 28 women) between 22 and 74 years of age (average 54 years) were available for analysis. Among the 35 treated wrists, 13 were left wrists and 22 were right wrists.
Release procedure
All the procedures were performed by the radiologist using an US unit (model Aplio 400; Toshiba Medical Systems, Tokyo, Japan) with a high-frequency transducer (14-18 MHz). The patient was positioned supine on a stretcher; the hand was set on its medial side on a table with slight ulnar deviation (see Online Supplemental Material, Fig. 1 ). A sterile working area was prepared.
First, a scan of the entire region was done with the US probe to locate the radial nerve's sensory branch (RNSB) and its divisions. Then local anaesthetic was injected with a 25-mm long, 25-G needle (orange hub) (see Online Supplemental Material, Fig. 1 ). The needle's entry point was about 1 cm distal and lateral to the styloid process of the radius; the needle was oriented on the coronal plane towards the distal end of the retinaculum. Two cc of 1% lidocaine HCl (Xylocaine; AstraZeneca, Rueil-Malmaison, France) was injected along the needle's path and into the synovial sheath of the first compartment extensor tendons ( Fig. 2 ; Online Supplemental Material, Movie 1).
Next, the base of a 50-mm long, 21-G needle (green hub) was manually curved to a 140°angle so that its bevel faced laterally (Figs. 3 and 4) . This curvature had two effects: it placed the needle in a completely horizontal position and made it possible to determine the bevel's orientation, even when it was hidden beneath the patient's skin.
The 21-G needle used the same trajectory as the anaesthetic injection with US guidance; its exact positioning was adjusted according to the type of De Quervain's tenosynovitis (Fig. 5) . Once the optimal position had been confirmed in the longitudinal and transverse planes ( Fig.  6 ; see Online Supplemental Material, Fig. 2 ), the radiologist slid the needle horizontally over the retinaculum (Movie 1 [Online Supplemental Material]) making about ten back-and-forth passes, while always keeping the needle's tip in sight to reduce the possibility of damaging Fig. 2 Ultrasonography is used to guide the local anaesthesia over the path of the retinaculum of the first extensor compartment being released. On this longitudinal view of the radial side of the wrist, the dotted line indicates the needle's theoretical path. Care is needed to avoid the small superficial vein (V') located in the path. The needle's path must reach the deep and distal portion of the thickened retinaculum (arrows) and position itself superficial to the extensor pollicis brevis tendon (E). The anisotropic area in the tendon (**) at the distal portion of the first compartment extensor is evidence of the sudden change in direction of the tendon fibres where the most stenosis exists. The anaesthetic agent will be injected along the needle's path and in the sheath of the first extensor compartment tendons. This injection may be difficult and generally only involves the distal recess of the tendon sheaths (blue oval shape). Deep to the tendons, the radial artery (A) and satellite veins (V) are visible at the anatomical snuffbox. R = radial styloid Fig. 3 Photograph of a US-guided release for de Quervain's tenosynovitis (simulation). The ulnar side of the hand rests on a small bolster made of a sterile drape which places the wrist in slight ulnar deviation; this makes it easier to approach the radial side of the first compartment without interference from the thumb column. The procedure is carried out in sterile conditions: sterile drapes (removed for the purpose of this photo), skin disinfection, use of sterile gel and sterile probe cover, sterile gloves. A pad of sterile gel (**) is placed between the probe and the patient's skin; this allows the operator to accurately locate the needle's path before it breaches the patient's skin neighbouring structures. In doing so, an experienced radiologist feels a slight resistance consistent with a transected fibrous structure. To release an intertendinous septum effectively, a 90°rotation of the needle was required to orient the bevel perpendicular to the fibres being cut (see Online Supplemental Material, Fig. 3 ).
When the radiologist felt a significant reduction in the retinaculum's resistance upon sliding the needle, 0.5 cc xylocaine was injected through the 21-G needle left in place (Movie 1 [Online Supplemental Material]). The fluid then easily diffuses in the EPB and APL sheath proximal and distal to the retinaculum. Next, 0.5 cc (or 3.5 mg) betamethasone (MSD, Courbevoie, France) was injected inside the tendon sheath.
Assessment of clinical outcomes
On the day of the procedure (D0), before starting, the radiologist performed a clinical examination with a Finkelstein test and asked the patients to rate their highest pain level in the prior 7 days (visual analogue scale (VAS) pain, 0-10) and their function using two questionnaires: Quick DASH (Quick Disabilities of the Arm, Shoulder and Hand outcome measure) and PRWE (Patient Rated Wrist Evaluation). US was also performed to analyse the location and thickness of the retinaculum, presence of a thickened intertendinous septum and presence of a hyperintense signal in Doppler mode. 5 Various types of de Quervain's tenosynovitis were found in our cohort, which had to be targeted differently in the release procedure. Here, the three types have drawings of an axial slice of the wrist and the corresponding ultrasonography images. -Type 1 consists of overall thickening (arrows on US image, thick red line on drawing) of the retinaculum surrounding the extensor pollicis brevis (E) and abductor pollicis longus (A). The 'X' marks the ideal area for partial transection of the retinaculum at its zenith, close of the surface of the underlying tendons. -In Type 2a, there is overall thickening of the retinaculum (arrows on US image, thick red line on drawing) and a thickened septum is present (arrow head on US image, red line on drawing). Release (XX) will occur in the common retinaculum where it joins with the septum and if possible, in the septum itself. -In Type 2b, the retinaculum around the extensor pollicis brevis is thickened (arrows on US image, thick red line on drawing) and a thickened septum is present (arrow head on US image, red line on drawing). The theoretical areas for partial release are marked with 'XX'. Fig. 4 Drawing of the position of the 21-G needle used in release of de Quervain's tenosynovitis. This is a dorsal view with the wrist resting on its ulnar side. The tendons of the first extensor compartment are surrounded by their retinaculum (light green), which has semicircular fibres (curved red lines) perpendicular to the long axis of the tendons. The 21-G needle enters the retinaculum on its distal side with the bevel angled laterally (close-up of needle in dotted circle). In this way, the bevel is perpendicular to the long axis of its fibres and is better able to transect them. A translation movement along the path of the retinaculum's apex will be applied to the needle. A = APL; E = EPB; R1 = extensor carpi radialis longus; R2= extensor carpi radialis brevis This US assessment was used to classify patients into one of three categories:
-Type 1: overall thickening of retinaculum in first compartment, without intertendinous septum -Type 2a: overall thickening of retinaculum in first compartment and presence of thickened intertendinous septum -Type 2b: EPL retinaculum is thickened in combination with a thickened intertendinous septum; the retinaculum around the APL has a normal appearance.
US was also used to evaluate the appearance of the RNSB, EPB and APL before and after the release procedure to detect any complications.
One month (M1) and 6 months (M6) after the procedure, the patients were seen again by the surgeon who then performed a new clinical examination and evaluated the highest pain level in the prior 7 days (VAS), QuickDASH and PRWE. Between these two planned visits, patients had the option to call the surgeon if the disease symptoms worsened.
Patients were contacted by telephone at the end of the study, an average of 12.1 months after the procedure (SD 7 months, range 6-24 months]), by a radiology resident to again determine the VAS pain level, QuickDASH, PRWE and evaluate the patient's satisfaction with their care: very satisfied, satisfied, somewhat satisfied, not satisfied.
Statistical analysis
The following tests were used in the statistical analysis: -McNemar's test to evaluate changes in the Finkelstein test -Paired Student's t-test for changes over time in the VAS pain, Quick DASH and PRWE assessments -Logistic regression to look for relationships between variables.
Results
Cadaver study
The following observations were made after dissecting the ten cadaver wrists that underwent US-guided release:
-every retinaculum is thin (average thickness of 0.5 mm) and has no intertendinous septum; -the retinaculum was not completely released in all cases.
Instead the result is partial thickness cuts over a portion of the retinaculum's length (Online Supplemental Material ,  Fig. 4) ; -there were no dislocations or tendon damage of the extensors in the first compartment; -no damage to the sensory branches of the radial nerve occurred; -no vascular damage occurred.
Clinical study
Status of patients on D0
The clinical characteristics of these patients were somewhat heterogeneous ( Table 1 ). The patients did not receive exactly the same conservative treatment initially. The patients were typically referred to the study' surgeon once non-operative treatments had failed (Table 2) .
US performed on D0 found the retinaculum was thickened in every patient (mean 1.9 mm; SD 0.4 mm). Doppler mode revealed a hyperintense signal in the retinaculum and tendon sheath in 71.4 % of cases (n=25/35). The breakdown of de Quervain's types in the study cohort was: 42.9 % Type 1 (n=15/35), 20 % Type 2a (n=7/35) and 37.1 % Type 2b (n=13/35). Thus, 57.1 % of patients (20/35) had an intertendinous septum. After the release procedure, US showed no damage to the RNSB, no complete transection of the retinaculum, and all the more, no tendon dislocation.
Outcomes
At the 1-month follow-up with the surgeon, the Finkelstein test was negative in 91.4 % of cases (n = 32/35), which was a highly significant improvement (p < 0.001). The 32 patients who had a negative Finkelstein test at 1 month had a clear improvement 7 days after the procedure on average (SD = 6.3). The three other patients (all of whom were subsequently operated on) felt they had improved after 1 week, but their pain reappeared in 2-3 weeks.
The VAS for pain, Quick DASH and PRWE all improved significantly within the first month (Table 3 ) (p < 0.001).
At 6 months and at the end of the study, these outcomes were maintained, as there were no differences relative to the 1-month outcomes (0.5 < p < 0.9).
When asked if they were satisfied with the outcome of the procedure:
-77.1 % (27/35) of patients were satisfied or very satisfied; among these 27 patients, seven had previously undergone one or two unsuccessful corticosteroid injections; -14.3 % (5/35) of patients were somewhat satisfied; three of these five patients had some improvement but had persistent background pain and did not want further treatment; the two other patients mentioned having significant pain for 3 days after the procedure.
-8.6 % (3/35) of patients were not satisfied and subsequently underwent surgery: 4 months after the procedure for two patients and 1 year for one patient. The appearance found during surgery was the same as the one found during the initial US examination: thickened septum and retinaculum (mean 1.9 mm) around the EPB in two cases (type 2b) and both tendons in one case (type 2a). There was no visible evidence of the US-guided percutaneous release.
Among the three patients who underwent secondary surgery, two of them were on sick leave for work. The surgical procedure was successful in two cases. In the third case, pain persisted and made it impossible for this patient to return to work.
The logistic regression analysis found no statistically significant relationship between patient satisfaction or need for surgical treatment and:
-retinaculum thickness -type of de Quervain's disease (1, 2a or 2b) -hyperintense signal in Doppler mode.
Conversely, a patient being on sick leave from work was a predictor of poor prognosis. The risk of undergoing surgery was increased 14 times (odds ratio (OR) = 14; p < 0.05).
Complications and costs
The average procedure time was 15 min (SD = 1.4); once the local anaesthesia was in place, the procedure was painless. Subcutaneous bruising appeared the day after the procedure in two patients (6 %) and had resolved after 1 week. The primary complaint after the procedure was an increase in pain on the evening of the procedure in six patients (17 % of cases) which lasted an average of 3.3 days (SD = 2). These minor incidents led us to adopt the following course of action after the procedure: application of a compressive dressing, recommendation to wear a brace and to take analgesics in case of pain, and 3 days off work. No other clinical complications were observed:
-no tendon dislocation during dynamic movements -no elective pain in the radial nerve's sensory territory -no skin atrophy at the needle entry point.
The cost of this US-guided release procedure is less than the cost of standard surgery for de Quervain's disease (Online Supplementary Material, Table 1 ). Standard surgical care involves a visit with the surgeon, ultrasonography, nerve block by an anaesthesiologist, surgical release, 3 weeks away from work and nursing care at home for the wound. The US-guided release procedure involves a diagnostic US examination, USguided release with corticosteroid injection, and 3 days away from work. Nursing care at home was not required since there was no wound.
Discussion
Overview of study
The purpose of our study was to evaluate the effectiveness of simultaneous corticosteroid injection and partial USguided release using a 21-G (0.8-mm) needle in patients with de Quervain's tenosynovitis. In our study, 91.4 % of patients (32/35) avoided surgery and were able to resume their activities with significantly less pain within 1 month. Among these patients, five were only 'somewhat satisfied' with the outcome: two because of pain in the days immediately after the procedure and three because of residual pain (less than initial pain levels), probably due to an insufficient partial release. Our procedure was effective, fast and low-cost. The 0.8-mm needle entry point means that nursing care at home is unnecessary and it allows patients to return to work after 3 days.
None of the typical complications of corticosteroid injection or surgery were observed. The context of sick leave from work was the only risk factor identified for a poor outcome (OR = 14). The presence of an intertendinous septum was not associated with treatment failure in our study.
Our good outcomes may appear contradictory to the results of our cadaver study in which only partial release was accomplished. In our clinical study after the release procedure, US showed no complete transection of the retinaculum. During surgery in the three operated patients there was no visible evidence of the US-guided percutaneous release, likely due to an incomplete release associated with well-organized scar tissue.
However, we can presume that partial release of the APL and EPB compartments with simultaneous corticosteroid injection might be sufficient to eliminate a patient's symptoms.
Comparison with other studies and techniques
US-guided percutaneous release with a needle has been performed successfully with another common type of stenosing tenosynovitis: trigger finger with A1 pulley transection [28] [29] [30] [31] . In the context of trigger finger [28] , the same technique induced partial anatomical release that was clinically effective. To our knowledge, there are few studies on percutaneous release of the first extensor tendon compartment with a needle. Guleç et al. [11] described a feasibility study in 48 cadaver wrists with an 18-G needle but no US guidance. Complete release was achieved in only 52.1 % of cases (25/ 48) . Several complications occurred in the tendons, including a 39.6 % (19/48) laceration rate. The absence of tendonrelated complications in our study can likely be attributed to the US-guided nature of our procedure. In a 2013 case report [27] , Peck described good clinical outcomes after performing tenotomy with an 18G needle and injecting platelet-rich plasma.
In the literature, simple corticosteroid injections are often described as being effective for de Quervain's disease. The most optimistic studies report a success rate between 82.5 % (52/63) [26] and 90 % (47/52) [32] . However, upon closer scrutiny of these studies, the first corticosteroid injection is Table 3 Change in the VAS for pain, QuickDASH and PRWE after release of the retinaculum of the first extensor compartment. All three outcome measures improved significantly (p < 0.001) 1 month after the procedure. At 6 months and the end of the study, the improvement is still present but did not change significantly, suggesting the initial improvement at 1 month is stable for at least 6 months (mean follow-up of 12.1 months) (13, 4) effective in only 58 % (30/52) [32] to 71 % of cases (45/63) [26] . Multiple injections are required to attain the reported 80-90 % success rate; however, the tradeoff is skin-related complications: cutaneous atrophy and melting of hypodermic fat in 31 % of cases (16/52) in the study by Anderson et al. [32] . The presence of an intertendinous septum is typically a risk factor for failure of this injection, as it limits diffusion of the injected product [25, 33] . This was not the case in our study. After the release in every patient, homogeneous diffusion of xylocaine and then cortisone in the sheath of both tendons was achieved, thereby optimizing the injection and limiting the subcutaneous diffusion of corticosteroids.
The historical gold standard treatment -surgery -is now reserved for failures of conservative treatment [32] . Its success rate ranges from 81 % to 100 % [20, 32] . However, surgical treatment implies a relatively long time away from work (3 weeks) and can result in various complications, such as volar dislocation of extensor tendons in the first compartment [22] , wound dehiscence [34] and damage to the radial nerve's sensory branches [34] . None of these complications occurred in our study.
Kazmers et al. [35] showed that certain psychosocial factors were associated with a higher rate of surgical treatment. In our study, 'being on sick leave' was identified as a predictor of poor outcomes, as it was associated with more frequent surgical treatment (OR = 14).
Limitations
Our study has limitations. The primary one is that a single radiologist performed all the release procedures. The operator-dependent nature of US-guided release was not evaluated.
Perspectives
Our study suggests that significant improvement after USguided release is achieved within the first month. Based on this finding, the treatment strategy could be adjusted at the 1-month follow-up visit: this same procedure could be repeated if the outcome is not satisfactory or the patient could be scheduled for a standard surgical release procedure.
Conclusion
US-guided release of the retinaculum of the first extensor compartment in the context of de Quervain's disease is feasible with a 21-G (0.8-mm) needle. This procedure is fast, not very painful, low risk and low cost. Return to work is possible after 3 days, even in manual laborers. The outcome is satisfactory in 77.1 % of cases, and 91.4 % of patients avoided surgical treatment. The effectiveness of this partial anatomical release is potentiated by concurrent injection of corticosteroids. The patients' symptoms and function improve within 1 month and are stable for at least 6 months.
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